[Methodology to develop a virtual reality training for good practices in the preparation of anti-cancer drugs].

Méthodologie pour développer une formation aux bonnes pratiques de préparation des anticancéreux en réalité virtuelle à 360°.

Journal

Annales pharmaceutiques francaises
ISSN: 0003-4509
Titre abrégé: Ann Pharm Fr
Pays: France
ID NLM: 2985176R

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 25 04 2019
revised: 10 12 2019
accepted: 11 12 2019
pubmed: 6 4 2020
medline: 30 3 2021
entrez: 6 4 2020
Statut: ppublish

Résumé

Describe the process for designing and creating SimUPAC 360°, a virtual reality training in anti-cancer drug production units. A multi-centre (a University Hospital, a General Hospital and a Cancer Control Centre), inter-professional (pharmacists, hospital pharmacy technicians and health executives) working group has been set up. It was based on videoconferencing and online document sharing. The work was divided into six phases: choice of target audience and training objectives, definition of the business model, development of the scenario, shooting and editing, creation of the training tool and finally tests, adjustments and validation of the tool. After brainstorming, 77 errors were proposed. Three areas have been defined: covering area, storage and production area, and isolator. They contained 15 errors among the 77 proposed and 20 points of interest. The shooting was carried out over 2 days, in 2 hospitals. Assembly was carried out by a service provider specialist in real virtuality. Before to go online, the tool was tested and validated by experts. The establishment of a multi-centric and interdisciplinary working group, the choice of target audience, pedagogical objectives and business model ensure the economic viability and scientific and technical robustness of the tool. The scenario development requires to define: activity areas and then, number, difficulty and typology of errors. Creation of a virtual reality training requires a consistent and structured methodology. This methodology will make it possible to develop other training scenarios.

Identifiants

pubmed: 32247514
pii: S0003-4509(20)30007-9
doi: 10.1016/j.pharma.2019.12.006
pii:
doi:

Substances chimiques

Antineoplastic Agents 0

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

324-334

Informations de copyright

Copyright © 2020 Académie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

G Descotes (G)

Service pharmacie, centre de lutte contre le cancer François-Baclesse, Caen, France.

M Moine (M)

Service pharmacie, hôpital Foch, Suresnes, France.

F Beau (F)

Service pharmacie, centre de lutte contre le cancer François-Baclesse, Caen, France.

V Noyer (V)

Service pharmacie, hôpital Robert-Bisson, Lisieux, France.

J-C Nicoulaud (JC)

Service pharmacie, hôpital Saint-Louis, Paris, France.

F Divanon (F)

Service pharmacie, centre de lutte contre le cancer François-Baclesse, Caen, France.

N Jourdan (N)

Service pharmacie, hôpital Saint-Louis, Paris, France.

A Bobay-Madic (A)

Service pharmacie, hôpital Robert-Bisson, Lisieux, France; Association pour le digital et l'information en pharmacie (ADIPh).

S Rodier (S)

Association pour le digital et l'information en pharmacie (ADIPh); Service pharmacie, centre hospitalier intercommunal Alençon-Mamers, France. Electronic address: simon.rodier@adiph.biz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH